KemPharm Participates in KP415 Late-Cycle Communication Meeting with FDA
CELEBRATION, Fla., Dec. 02, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company focused on the discovery...
CELEBRATION, Fla., Dec. 02, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company focused on the discovery...
SOUTH SAN FRANCISCO, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company...
NEW YORK, Dec. 02, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the publication of data from...
On-track to report topline results from low-dose cohort by end of 2020NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 02,...
Adamas to acquire global rights to OSMOLEX ER® for $7.5 million Company to focus on maximizing commercial opportunity for Upneeq™...
- Topline data expected in first half of 2021 - STAMFORD, Conn., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics,...
ACTengine® IMA200 clinical trial series continues scaling globally; initial analysis for patients in ACTengine® dose escalation is on track for...
CRANBURY, N.J., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced the election and appointment of Michael...
NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, Dec. 02, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical (OTCQB: TOMDF), an in vitro diagnostics...
Skylight Health graduates to the highest tier of the OTC Markets offering greater visibility for the Company’s shares and improved...
New data show safety and efficacy of roxadustat in treating anemia secondary to lower-risk myelodysplastic syndromes (MDS) regardless of ring...
SOUTH SAN FRANCISCO, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the...
- Call will take place on Friday, December 11, 2020 at 11:00 AM ET TORONTO and HOUSTON, Dec. 02, 2020 (GLOBE...
Amended terms will provide added flexibility to help drive the growth of the CompanyEMERYVILLE, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE)...
As part of this agreement Adamas will acquire the global rights to OSMOLEX ER®EMERYVILLE, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE)...
NEW YORK, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its support for #BlanketChange,...
PRINCETON, N.J.--(BUSINESS WIRE)--CitiusTech, a leading provider of healthcare technology and services, announced today that it has received the Healthcare Competency...
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN...
Premium supplement manufacturer, Sunergetic has worked with their manufacturers to ensure customers continue to get their popular Sunergetic supplements amid...